Open CuzickA opened 1 year ago
Have not added in any comments in the phenotype annotation sections, unsure what to include.
Apart from phenotype annotation comments, curation completed pending review.
Hi @jingluodatacurator, before I start checking this older curation session, please could you
1) email me your highlighted PDF 2) add a short summary of the expt to this GitHub, including how you found the UniProt ids etc 3) double check the annotations with your new additional curation knowledge and personal curation checklist 4) Please let me know when you've done the above and then I'll check the session. Thanks
Summary of expt. :
Sequence analysis of cyp51A revealed a number of point mutations. The five ITC-resistant strains (CM-1252, CM-1245, CM-2158, CM-2159, and CM-2164) each had a single nucleotide substitution in codon 220 (encodes methionine), resulting in the introduction of valine, lysine, or threonine (Table 1).
The cyp51A alleles from strains CM-1252, CM-2159, and CM-2164 were PCR amplified, and each was individually electroporated into the wild-type A. fumigatus strain CM-237. Electroporation was carried out; transformants were selected on medium containing ITC as described previously. ITC-resistant transformants appeared after 2 to 7 days of incubation. The transformants were labelled with a “T” followed by a roman numeral (Table 1). The numbers of ITC-resistant transformants obtained using the cyp51A genes from strains CM-2159, CM-1252, and CM-2164 were four (T-III, T-VI, T-VII and T-XI), one (T-XII), and one (T-XXII), respectively. All six appeared to have incorporated the mutated cyp51A allele. With the exception of the original mutation at codon 220, none of the transformants had any other mutations in either cyp51A or cyp51B. In general, the transformants exhibited susceptibility profiles similar to those of the original clinical isolates (Table 1).
Uniprot IDs: author provided GenBank AAK73659 and AAK73660 for cyp51A and cyp51B respectively, and they were used in Uniprot to find IDs Q9P8R0, Q96W81.
Strains: CM-237 is sensitive to azole drugs and was used for replacement mutation expt.
Genotype creation:
cyp51A(aaM220V), cyp51A(aaM220K), cyp51A(aaM220T) genotypes have been created.
T-III, T-VI, T-VII, T-XI, T-XII and T-XXII have been curated for itraconazole: T-III, T-VI, T-VII, T-XI are related to cyp51A(aaM220K); T-XII is related to cyp51A(aaM220V); T-XXII is related to cyp51A(aaM220T).
Curation completed pending review by @CuzickA thanks.
Current annotations
Uniprot IDs: author provided GenBank AAK73659 and AAK73660 for cyp51A and cyp51B respectively, and they were used in Uniprot to find IDs Q9P8R0, Q96W81.
AC checking UniProt It is true that the author provided GenBank AAK73659 for Af Cyp51A which pulls up UniProt id Q9P8R0. However, this is an unreviewed entry https://www.uniprot.org/uniprotkb/Q9P8R0/entry.
We have curated Af Cyp51A in other publications/sessions and have used the UniProt Swiss-Prot reviewed entry https://www.uniprot.org/uniprotkb/Q4WNT5/entry
Therefore I think the UniProt id needs changing to Q4WNT5.
Currently there are no annotations in this session to Cyp51B.
I still need to check the genotype further but it doesn't look like these are nt substitutions. They should be AA substitutions.
Hi @jingluodatacurator, please can you
1) change the UniProt id as suggested above
2) re-make the genotypes following the information highlighted in blue
Genotype creation:
T-III, T-VI, T-VII, T-XII, T-XII and T-XXII have been curated for itraconazole.
Hi @jingluodatacurator, when you record the 'Genotype creation', please can you add in the actual genotypes added into PHI-Canto? These can then be linked to the mutant line names you have recorded here. This makes the checking of the session more straight forward.
Uniprot IDs: author provided GenBank AAK73659 and AAK73660 for cyp51A and cyp51B respectively, and they were used in Uniprot to find IDs Q9P8R0, Q96W81.
Strains: CM-237 was used for replacement mutation expt.
@jingluodatacurator, likewise here when making a note of the strain 'CM-237' please could you add whether this is sensitive or resistant to the chemical. This makes it more straight forward to check the sessions.
I have added a GO MF annotation
AC next steps 1) Check JL's edits suggested above 2) Once we have the correct genotypes, try and add in AE alteration in archetype
(It looks like the key annotations have been made -just need some edits. No further expt to curate in this paper) (no need for new strain or PHIPO terms)
I have added a GO MF annotation
AC next steps
- Check JL's edits suggested above
- Once we have the correct genotypes, try and add in AE alteration in archetype
(It looks like the key annotations have been made -just need some edits. No further expt to curate in this paper) (no need for new strain or PHIPO terms)
Hi @CuzickA, all comments have been responded and edits have been done to curation and notes for GitHub above, please check thanks.
Hi @jingluodatacurator, the only changes to this sessions that I can see is the changed UniProt id
Genotype creation: T-III, T-VI, T-VII, T-XII, T-XII and T-XXII have been curated for itraconazole.
Hi @jingluodatacurator, when you record the 'Genotype creation', please can you add in the actual genotypes added into PHI-Canto? These can then be linked to the mutant line names you have recorded here. This makes the checking of the session more straight forward.
@jingluodatacurator, please add the requested information into this comment.
Uniprot IDs: author provided GenBank AAK73659 and AAK73660 for cyp51A and cyp51B respectively, and they were used in Uniprot to find IDs Q9P8R0, Q96W81. Strains: CM-237 was used for replacement mutation expt.
@jingluodatacurator, likewise here when making a note of the strain 'CM-237' please could you add whether this is sensitive or resistant to the chemical. This makes it more straight forward to check the sessions.
@jingluodatacurator, please add the requested information into this comment.
Hi @jingluodatacurator, the only changes to this sessions that I can see is the changed UniProt id
Hi @CuzickA, that's rather strange. I have made changes in genotypes from nt substitutions to aa substitutions.
Genotype creation: T-III, T-VI, T-VII, T-XII, T-XII and T-XXII have been curated for itraconazole.
Hi @jingluodatacurator, when you record the 'Genotype creation', please can you add in the actual genotypes added into PHI-Canto? These can then be linked to the mutant line names you have recorded here. This makes the checking of the session more straight forward.
@jingluodatacurator, please add the requested information into this comment.
Hi @CuzickA, I have updated this in my original comment at the top.
Uniprot IDs: author provided GenBank AAK73659 and AAK73660 for cyp51A and cyp51B respectively, and they were used in Uniprot to find IDs Q9P8R0, Q96W81. Strains: CM-237 was used for replacement mutation expt.
@jingluodatacurator, likewise here when making a note of the strain 'CM-237' please could you add whether this is sensitive or resistant to the chemical. This makes it more straight forward to check the sessions.
@jingluodatacurator, please add the requested information into this comment.
Hi @CuzickA, likewise, I have updated this in my original comment at the top.
Thanks, missed those updates as the ticket is getting long.
Hi @CuzickA, that's rather strange. I have made changes in genotypes from nt substitutions to aa substitutions.
These genotypes are still incorrect @jingluodatacurator
It looks as though you have changed the allele type from nt to AA and not updated the nt symbols to AA residue symbols as highlighted in blue in the comment above.
Genotype creation:
cyp51A(aaA220G), cyp51A(aaT220A), cyp51A(aaT220C) genotypes have been created. T-III, T-VI, T-VII, T-XII, T-XII and T-XXII have been curated for itraconazole.
@jingluodatacurator, this comment will also need updating above please when you change the genotypes. Also can you note which PHI-Canto genotypes 'T-III, T-VI, T-VII, T-XII, T-XII and T-XXII' relate to please. This will make it easier to understand the curation for checking and if we need to go back to it. Thanks.
Hi @CuzickA, that's rather strange. I have made changes in genotypes from nt substitutions to aa substitutions.
These genotypes are still incorrect @jingluodatacurator
It looks as though you have changed the allele type from nt to AA and not updated the nt symbols to AA residue symbols as highlighted in blue in the comment above.
Hi @CuzickA, I got confused but have now corrected them thanks.
Genotype creation:
cyp51A(aaA220G), cyp51A(aaT220A), cyp51A(aaT220C) genotypes have been created. T-III, T-VI, T-VII, T-XII, T-XII and T-XXII have been curated for itraconazole.
@jingluodatacurator, this comment will also need updating above please when you change the genotypes. Also can you note which PHI-Canto genotypes 'T-III, T-VI, T-VII, T-XII, T-XII and T-XXII' relate to please. This will make it easier to understand the curation for checking and if we need to go back to it. Thanks.
Hi @CuzickA, I have updated the original comment again at the top thanks.
looks good, thanks @jingluodatacurator
AC next steps
1) Try and add in AE alteration in archetype
AE alteration in archetype
Info not listed in Nichola's S file but it is in Mair et al 2016
cyp51A(aaM220V) 'M220V; Cyp51A; ASPEFU' cyp51A(aaM220K) 'M220K; Cyp51A; ASPEFU' cyp51A(aaM220T) 'M220T; Cyp51A; ASPEFU'
AE added below
AC next steps
1) check AE alteration in archetype with Nichola
Then session will be ready for approval.
Curated by @jingluodatacurator
https://canto.phi-base.org/curs/6b96165af86b6fa7